ROCKWELL MEDICAL Business Summary

Rockwell Medical, Inc. (RMTI) operates as a leading manufacturer and distributor of hemodialysis concentrates and ancillary products, primarily generating revenue through high-volume product sales to dialysis providers. The company’s business model is centered on its Hemodialysis Concentrates segment, which produces liquid and dry acid and bicarbonate concentrates essential for treating end-stage renal disease (ESRD), and an Ancillary Products segment that distributes third-party dialysis supplies. As of early 2026, Rockwell has solidified its position as the second-largest supplier in the United States, maintaining a near-duopoly in the concentrate market alongside its principal competitor, Fresenius Medical Care. Other direct competitors include Baxter International Inc., B. Braun Melsungen AG, and Nipro Renal Solutions. Rockwell distinguishes itself by focusing on manufacturing redundancy and supply chain reliability, recently expanding its footprint through long-term contract renewals with major providers and the acquisition of regional competitors to capture market share from vertically integrated giants. Originally founded in 1996 by Robert L. Chioini and Gary D. Lewis, the company is currently led by President and CEO Mark Strobeck, Ph.D., who brings over 20 years of life sciences leadership from firms such as Aquilo Partners and Assertio Holdings. The executive team includes Senior Vice President and CFO Jesse Neri, Chief Operating Officer Heather R. Hunter, and Executive Vice President and Chief Legal Officer Megan Timmins. The board is chaired by Robert S. Radie, a veteran biotech executive, and recently added Joseph H. Dawson, formerly of Nipro Medical Corporation, to bolster its operational expertise. Notable institutional backing includes significant positions held by Armistice Capital, Vanguard Group, and BlackRock, reflecting a shareholder base focused on the company's strategic pivot toward sustained profitability and portfolio diversification within the renal care sector.